VR Logo

Sequent Scientific Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

38 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1985

Chairman: Gopakumar G Nair

Managing Director: Manish Gupta

Group: --

Listing: NSE: SEQUENT, BSE: 512529

Headquarters: Thane, Maharashtra

Website: http://www.sequent.in/

Key Facts

Market cap: R 2,353.32 Cr

Revenue (TTM): R 1,160.56 Cr

Earnings (TTM): R 85.15 Cr

Cash: R 72.51 Cr

Total Debt: R 318.10 Cr

Promoters' ownership: 56.15%

Liquidity: High

52 Week range: R 62.80 - 99.35

Face value: R2.00

Shares outstanding: 24,83,70,995

Stock Performance

Time Period Sequent Scientific S&P BSE Healthcare S&P BSE Small Cap
YTD34.305.785.94
1 month11.670.69-2.24
3 months45.886.018.68
1 Year43.064.547.32
3 Years-12.46-2.532.22
5 Years0.26-1.985.13
10 Years13.3111.386.14
As on 24-Feb-2020
Year Sequent Scientific S&P BSE Small Cap S&P BSE Healthcare
20194.13-6.85-3.55
2018-30.98-23.41-5.89
2017-10.9959.640.49
2016-55.481.77-12.88
2015144.446.7615.06
2014156.0369.2447.43
2013-10.09-11.2322.55